Currently, they have prescriptive authority for these three types of diseases: high cholesterol, diabetes and high blood pressure in specific disease management protocols. [47] The CDTM is an extension of the traditional pharmacist sector that enables pharmacist-led medication problem management (DRPs), with a focus on a collaborative and interdisciplinary approach to pharmacy practice in the healthcare sector. The conditions for a CPA are set by the pharmacist and the cooperating doctor, although there are online templates. CSAs may be specific to a patient population of interest to both parties, a clinical situation or a specific disease condition and/or may draw up an evidence-based protocol for the management of patient treatment under the CPA. ASAs have been the subject of intense debate in pharmacy and the medical professions. Most importantly, the debate about why pharmacists have an interest in strengthening this authority is to improve patient care through interdisciplinary cooperation. [5] The modern concept of collaborative practice has been partly derived to avoid the controversial notion of dependent prescribing authority. [4] Pharmacists who want to develop an agreement on collaborative practices may need help figuring out where to start. To support this process, a toolkit entitled “Advancing Team-Based Care through Collaborative Practice Agreements” has been developed. .

. .

: Uncategorized

Comments are closed.